evidence: To date, Biological E. Limited has manufactured 30 crore doses of CORBEVAXTM and have already supplied nearly 10 crore doses to the Government of India. Currently, over 3 crore doses of CORBEVAXTM have been administered in children between 12-15 years of age. And now, with an approval for the 5-12-year age group, this move will not only reduce the risks children face from the infectious disease, but it will also enable them to concentrate on their education and social development, which were severely impacted by the pandemic. Getting their kids vaccinated will also help ease parents' concerns while sending them to school. [...] After examining a number of proposals from India, the World Health Organisation's Advisory Committee on Vaccine Product Development (ACPDV) selected Biological E. Limited as a recipient of mRNA technology from the WHO technology transfer hub. WHO and their partners will work with the Indian government and BE to develop a roadmap and put in place the necessary training and support for BE to start producing mRNA vaccines as soon as possible.